Join to View Full Profile
520 East 70th StreetStarr Pavilion, 3rd FloorNew York, NY 10021
Phone+1 646-962-2065
Dr. Schafer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1979
University of ChicagoResidency, Internal Medicine, 1973 - 1976
Perelman School of Medicine at the University of PennsylvaniaClass of 1973
Certifications & Licensure
IL State Medical License 1974 - Present
NY State Medical License 2007 - 2025
PA State Medical License 2002 - 2008
TX State Medical License 1990 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1986
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 7 citationsThrombotic, Cardiovascular, and Microvascular Complications of Myeloproliferative Neoplasms and Clonal Hematopoiesis (CHIP): A Narrative Review.Andrew I Schafer, Douglas L Mann
Journal of Clinical Medicine. 2024-10-12 - 73 citationsThe pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms.Hans Carl Hasselbalch, Margitta Elvers, Andrew I. Schafer
Blood. 2021-04-22 - 12 citationsThrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms.Andrew I. Schafer
Hematology/oncology Clinics of North America. 2021-01-05
Abstracts/Posters
- Recombinant Interferon-_ Reduces Thrombotic Events in Patients with Polycythemia VeraAndrew I. Schafer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall SurvivalAndrew I. Schafer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Douglas L. Mann MDNovember 12th, 2016
Why ICMJE’s Data Sharing Proposal Is Both Too Strong & Too WeakFebruary 15th, 2016
Grant Support
- Revitalization Of The Nation?S Physician-Scientist WorkforceNational Heart, Lung, And Blood Institute2007
- Regulation Of Platelet-Endothelial InteractionsNational Heart, Lung, And Blood Institute2003–2006
- Vascular Cell Cationic Amino Acid Transport &MetabolismNational Heart, Lung, And Blood Institute1999–2002
- Regulation Of Platelet/Endothelial InteractionsNational Heart, Lung, And Blood Institute1997–2001
- Regulation Of Platelet-Endothelial InteractionsNational Heart, Lung, And Blood Institute1989–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
